These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1113 related items for PubMed ID: 14968144

  • 1. Secondary prevention after acute myocardial infarction in four Canadian provinces, 1997-2000.
    Pilote L, Beck CA, Karp I, Alter D, Austin P, Cox J, Humphries K, Jackevicius C, Richard H, Tu JV, Canadian Cardiovascular Outcomes Research Team.
    Can J Cardiol; 2004 Jan; 20(1):61-7. PubMed ID: 14968144
    [Abstract] [Full Text] [Related]

  • 2. Pharmacological treatment of congestive heart failure in Canada: a description of care in five provinces.
    Cox JL, Ramer SA, Lee DS, Humphries K, Pilote L, Svenson L, Tu JV, Canadian Cardiovascular Outcomes Research Team Investigators.
    Can J Cardiol; 2005 Mar 15; 21(4):337-43. PubMed ID: 15838560
    [Abstract] [Full Text] [Related]

  • 3. Acute treatment of myocardial infarction in Canada 1999-2002.
    Jackevicius CA, Alter D, Cox J, Daly P, Goodman S, Filate W, Newman A, Tu JV, Canadian Cardiovascular Outcomes Research Team.
    Can J Cardiol; 2005 Feb 15; 21(2):145-52. PubMed ID: 15729413
    [Abstract] [Full Text] [Related]

  • 4. Regional variation in the management of acute myocardial infarction in the province of Quebec.
    Rodrigues EJ, Simpson E, Richard H, Pilote L.
    Can J Cardiol; 2002 Oct 15; 18(10):1067-76. PubMed ID: 12420042
    [Abstract] [Full Text] [Related]

  • 5. The management of patients who have suffered an acute myocardial infarction in a tertiary care centre.
    Haddad H, Searles G, Gillis A.
    Can J Cardiol; 2001 Feb 15; 17(2):179-83. PubMed ID: 11223488
    [Abstract] [Full Text] [Related]

  • 6. Drug prescriptions after acute myocardial infarction: dosage, compliance, and persistence.
    Simpson E, Beck C, Richard H, Eisenberg MJ, Pilote L.
    Am Heart J; 2003 Mar 15; 145(3):438-44. PubMed ID: 12660666
    [Abstract] [Full Text] [Related]

  • 7. Factors associated with the use of evidence-based therapies after discharge among elderly patients with myocardial infarction.
    Austin PC, Tu JV, Ko DT, Alter DA.
    CMAJ; 2008 Oct 21; 179(9):901-8. PubMed ID: 18936455
    [Abstract] [Full Text] [Related]

  • 8. Discharge prescriptions following admission for acute myocardial infarction at tertiary care and community hospitals in Quebec.
    Beck CA, Lauzon C, Eisenberg MJ, Huynh T, Dion D, Roux R, Racine N, Carignan S, Diodati JG, Charbonneau F, Lévesque C, Pouliot J J, Pilote L L.
    Can J Cardiol; 2001 Jan 21; 17(1):33-40. PubMed ID: 11173312
    [Abstract] [Full Text] [Related]

  • 9. Parabolas of medication use and discontinuation after myocardial infarction--are we closing the treatment gap?
    Hudson M, Richard H, Pilote L.
    Pharmacoepidemiol Drug Saf; 2007 Jul 21; 16(7):773-85. PubMed ID: 17486661
    [Abstract] [Full Text] [Related]

  • 10. Pharmacological treatment after acute myocardial infarction from 2001 to 2006: a survey in Italian primary care.
    Filippi A, D'Ambrosio G, Giustini SE, Pecchioli S, Mazzaglia G, Cricelli C.
    J Cardiovasc Med (Hagerstown); 2009 Sep 21; 10(9):714-8. PubMed ID: 19465867
    [Abstract] [Full Text] [Related]

  • 11. Hospital variation in use of secondary preventive medicine after discharge for first acute myocardial infarction during 1995-2004.
    Rasmussen S, Abildstrom SZ, Rasmussen JN, Gislason GH, Schramm TK, Folke F, Køber L, Torp-Pedersen C, Madsen M.
    Med Care; 2008 Jan 21; 46(1):70-7. PubMed ID: 18162858
    [Abstract] [Full Text] [Related]

  • 12. Trends in the in-hospital treatment of acute myocardial infarction between 1984 and 1993 - The Halifax County MONICA Project.
    Gregor RD, Bata IR, Brownell B, Wolf HK.
    Can J Cardiol; 2000 May 21; 16(5):596-603. PubMed ID: 10833539
    [Abstract] [Full Text] [Related]

  • 13. Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH Registry.
    Kumar A, Fonarow GC, Eagle KA, Hirsch AT, Califf RM, Alberts MJ, Boden WE, Steg PG, Shao M, Bhatt DL, Cannon CP, REACH Investigators.
    Crit Pathw Cardiol; 2009 Sep 21; 8(3):104-11. PubMed ID: 19726929
    [Abstract] [Full Text] [Related]

  • 14. Adherence to statins, beta-blockers and angiotensin-converting enzyme inhibitors following a first cardiovascular event: a retrospective cohort study.
    Blackburn DF, Dobson RT, Blackburn JL, Wilson TW, Stang MR, Semchuk WM.
    Can J Cardiol; 2005 May 01; 21(6):485-8. PubMed ID: 15917876
    [Abstract] [Full Text] [Related]

  • 15. Trends in incidence and mortality from acute myocardial infarction in Nova Scotia and Saskatchewan 1974 to 1985. The Nova Scotia-Saskatchewan Cardiovascular Disease Epidemiology Group.
    Can J Cardiol; 1992 Apr 01; 8(3):253-8. PubMed ID: 1576559
    [Abstract] [Full Text] [Related]

  • 16. Suboptimal use of evidence-based medical therapy in patients with acute myocardial infarction from the Korea Acute Myocardial Infarction Registry: prescription rate, predictors, and prognostic value.
    Lee JH, Yang DH, Park HS, Cho Y, Jeong MH, Kim YJ, Kim KS, Hur SH, Seong IW, Hong TJ, Cho MC, Kim CJ, Jun JE, Park WH, Chae SC, Korea Acute Myocardial Infarction Registry Investigators.
    Am Heart J; 2010 Jun 01; 159(6):1012-9. PubMed ID: 20569714
    [Abstract] [Full Text] [Related]

  • 17. Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction.
    Gislason GH, Rasmussen JN, Abildstrøm SZ, Gadsbøll N, Buch P, Friberg J, Rasmussen S, Køber L, Stender S, Madsen M, Torp-Pedersen C.
    Eur Heart J; 2006 May 01; 27(10):1153-8. PubMed ID: 16399775
    [Abstract] [Full Text] [Related]

  • 18. Changes in the treatment and outcomes of acute myocardial infarction in Quebec, 1988-1995.
    Pilote L, Lavoie F, Ho V, Eisenberg MJ.
    CMAJ; 2000 Jul 11; 163(1):31-6. PubMed ID: 10920727
    [Abstract] [Full Text] [Related]

  • 19. Identifying opportunities to address the congestive heart failure burden: the Improving Cardiovascular Outcomes in Nova Scotia (ICONS) study.
    Howlett JG, Johnstone DE, Sketris I, O'Reilly M, Horne GS, Cox JL, Improving Cardiovascular Outcomes in Nova Scotia investigators.
    Can J Cardiol; 2003 Mar 31; 19(4):439-44. PubMed ID: 12704493
    [Abstract] [Full Text] [Related]

  • 20. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.
    Vermeer NS, Bajorek BV.
    J Clin Pharm Ther; 2008 Dec 31; 33(6):591-601. PubMed ID: 19138236
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 56.